Mutated TP53 genes are most prevalent in tumor cells, and it has been shown that inactivation of p53 via mutation or loss leads to enhanced G6PD and PPP activity as well as biosynthesis and NADPH production, resulting in tumor progression [26]. This evidence concerns the gene TP53 and neoplasm.